Phocas Financial’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
Phocas Financial's PTCT Position: Q3 2026 in Review
Phocas Financial sold out of PTC Therapeutics (PTCT) in Q3 2026, closing a stake of 46,170 shares — an estimated $3.77M sold.
Phocas Financial first reported a position in PTCT in Q3 2022 and held it in 9 quarters. The position peaked at $4.94M in Q1 2023. 275 funds tracked by Wall St. Rank hold PTCT as of Q3 2026.
- Phocas Financial reported no remaining PTC Therapeutics position as of Q3 2026 after selling out during the quarter.
- Phocas Financial sold 46,170 PTC Therapeutics shares in Q3 2026, an estimated $3.77M.
- Phocas Financial first reported a position in PTC Therapeutics in Q3 2022 and held it in 9 quarters.
- Phocas Financial's PTC Therapeutics position peaked at $4.94M in Q1 2023.
- 275 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2026.
Based on Phocas Financial's 13F filing for Q3 2026.